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In this study we developed and evaluated a new PCR-based typing assay, directed to the VD2 region of the
omp1 gene, for the detection and typing of urogenital Chlamydia trachomatis infections. A nested VD2 PCR-
reverse line blot (RLB) assay was developed for the typing of nine different urogenital serovars of C. tracho-
matis. The assay developed was tested with reference strains of C. trachomatis serovars and cervical scrapes of
86 Colombian women previously found to be positive for C. trachomatis by using plasmid PCR. Two sets of
primers directed to the VD2 region of the omp1 gene of C. trachomatis were designed, and fragments of 220 and
166 bp were generated in the primary and nested PCRs, respectively. In addition, an RLB assay was developed
to identify nine different urogenital serovars of C. trachomatis (Ba, D, E, F, G, H, I, J, and K) and group
controls, including group B (Ba, D, and E), group C (I, J, K, and H), and an intermediate group (F and G).
Using this assay, we were able to type 81 of the 86 samples (94.2%). Of these samples, 91.3% were single C.
trachomatis infections, and 8.7% were multiple infections. The most common serovars identified were serovars
D (22.2%), F (18.5%), G (13.6%), and E (12.3%). Of the women with multiple C. trachomatis infections, >50%
contained both serovars D and E. The nested VD2 PCR-RLB developed is a simple, fast, and specific method
for the identification of individual urogenital C. trachomatis serovars previously detected by using plasmid
PCR. Moreover, it is an appropriate method for studying multiple C. trachomatis infections and for use in large
epidemiological studies.
Chlamydia trachomatis is one of the most common patho-
gens of sexually transmitted diseases worldwide.
Initially, 15 prototypic serovars labeled A to K and L1, L2,
and L3 were identified based on immunoepitope analysis of the
major outer membrane protein (MOMP) with monoclonal and
polyclonal antibodies (7, 10). On the basis of the pathogenic
potential, the serovars A, B, Ba, and C are commonly associ-
ated with trachoma, D to K are commonly associated with
urogenital infections, and L1, L2, and L3 are commonly asso-
ciated with lymphogranuloma venereum. In addition, based on
amino acid similarity, the serovars have been grouped in three
different serogroups: group B (B, Ba, D, Da, E, L1, L2, and
L2a), group C (A, C, H, I, Ia, J, Ja, K and L3), and an
intermediate group (F and G) (20).
The typing of C. trachomatis infection is important for epide-
miological and vaccination studies. In addition, the knowledge of
pathogenesis and transmission rates of C. trachomatis serovars are
important topics in clinical and basic research (1, 3, 14).
To study the epidemiology of C. trachomatis infections, dif-
ferent laboratory techniques for C. trachomatis serovar iden-
tification have been developed in the last few years. These
techniques include standard MOMP serotyping, restriction
fragment length polymorphism (RFLP) analysis of the PCR-
amplified omp1 gene, and nucleotide sequencing of the omp1
gene (3, 4, 12, 13, 19). Compared to immunotyping, the geno-
typing methods are more sensitive and specific for C. tracho-
matis serovar identification. In addition, the multiple passages
in cell culture and the need for a large panel of monoclonal
antibodies are the principal disadvantages of MOMP serotyp-
ing (1, 9).
Although nucleotide sequencing and RFLP analysis of the
omp1 gene are good methods for C. trachomatis identification,
they are still very laborious and not suitable for typing of a
large number of clinical samples and for the detection and
typing of multiple C. trachomatis infections. In addition, the
primers generally used in the RFLP-PCR analyses generate a
quite large fragment (1.1 kb) of the omp1 gene. Therefore,
samples without good DNA quality are frequently negative and
cannot be typed.
Here we report the development of a nested VD2 PCR,
followed by an easy and rapid reverse line blot (RLB) assay
for identification of the most common urogenital serovars of
C. trachomatis. In addition, we used this assay to type the
C. trachomatis infections found in cervical scrapes by using
plasmid PCR from women from the general population of
Colombia.
MATERIALS AND METHODS
C. trachomatis reference strains and cervical scrapes. To evaluate the sensi-
tivity and specificity of the C. trachomatis VD2 PCR and RLB typing, 12 different
reference serovars were used (D, D1, E, Ba, I, J, Jv, K, H, G, G1, and F) as
previously described in the omp1 RFLP-PCR method (9).
In addition, DNAs from cervical scrapes of 86 women that were initially
C. trachomatis positive by C. trachomatis plasmid PCR in a cohort study from
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Colombia were purified by using a filter tube-based isolation method (High Pure
PCR Template Preparation kit; Roche), suspended in 200 l of elution buffer
according to the manufacturer’s instructions, and used for PCR analysis.
Informed consent was obtained from all participants included in the cohort
study and the ethical committee of the International Agency for Cancer Re-
search (Lyon, France) approved the study protocol.
PCR amplification. Plasmid PCR was performed as previously described (9).
With respect to the omp1 VD2 PCR, the primary PCR amplification was per-
formed in a final volume of 50 l containing 50 mM KCl, 1.5 mM MgCl2, a 0.2
mM concentration of each deoxynucleoside triphosphate, 25 pmol of each of the
MCTV2S and MCTV2AS primers (primer sequences are given in Results) (Euro-
gentec, Seraing, Belgium), 1 U of Taq polymerase (AmpliTaq; Cetus/Perkin-
Elmer), and 10 l of isolated nucleic acid. Amplification was performed in a
Perkin-Elmer 9600 thermocycler. The optimal amplification conditions for the
PCR were as follows: denaturation for 4 min at 95°C, followed by 50 cycles of
amplification. Each cycle consisted of 1 min at 95°C, 2 min at 55°C, and 1.5 min at
72°C. The final elongation step was extended for another 4 min. The amplified DNA
was analyzed by 1.5% agarose gel electrophoresis and ethidium bromide staining.
Then, 2 l of the primary PCR product was used for the nested PCR, which
was done with the same reagents and conditions (50 cycles) as the primary PCR,
except for the primers, which were MCTV2N and MCTV2AN (primer sequences
are shown in Results).
The stocks of 12 different reference C. trachomatis serovars were amplified by
the same protocol. Negative controls, with all of the reaction components but
void of DNA, and positive controls, with C. trachomatis serovar D, were included
in each experiment.
RLB analysis. RLB analysis was performed by using a system that has been
described previously (5, 6, 11, 16). In this method, oligonucleotide probes con-
taining a 5 amino group are covalently attached to a membrane in parallel lines
by using a miniblotter. After binding of the oligonucleotides, the membrane is
removed from the miniblotter and rotated 90°. The slots of the miniblotter, which
now are perpendicular to the oligonucleotide lines, are filled with biotin-labeled
target DNA (usually biotinylated PCR products). Hybridization takes place in
the miniblotter and is visualized by using peroxidase-labeled streptavidin, which
interacts with the biotin of the probe, followed by enhanced chemiluminescence
(ECL) detection.
Probes. Twelve different oligonucleotide probes (Isogen, Maarssen, The Neth-
erlands) directed against the VD2 region of MOMP gene of 12 different uro-
genital serovars of C. trachomatis were selected by using a primer/probe selection
software (Oligo). In addition, three different probes were identified to use as
controls for the three principal groups of C. trachomatis serovars: group B (D, D,
E, and Ba), group C (I, J, Jv, K, and H), and the intermediate group (F and G).
The probes were designed to have similar melting temperatures (Tm) in such a
way that the Tm was ca. 55°C and the length of the oligonucleotide probes was
20 bp. The sequences of the RLB probes are shown in Table 2.
Covalent coupling of oligonucleotide probes to the membrane. All oligonucle-
otide probes were synthesized with a 5-terminal amino group, which was used to
covalently link the oligonucleotides to an activated negatively charged Biodyne C
membrane (5, 16).
Hybridization with PCR products and detection. Briefly, 10 l of the PCR
products were added to 150 l of 2 SSPE (1 SSPE is 0.18 M NaCl, 10 mM
NaH2PO4, and 1 mM EDTA [pH 7.7])–0.1% sodium dodecyl sulfate (SDS)
(Roche, Mannheim, Germany), and the PCR products were then denatured for
10 min at 99°C and cooled in ice. The membrane (with the oligonucleotide
probes) was incubated for 5 min at room temperature in 2 SSPE–0.1% SDS
and placed in a miniblotter in such a way that the slots were perpendicular to the
line pattern of the applied oligonucleotides. The slots were filled with the diluted
PCR products (160 l) and hybridized for 60 min at appropriate temperatures.
The samples were removed by aspiration, and the membrane was washed twice
in 2 SSPE–0.5% SDS for 10 min at 51°C. Subsequently, the membrane was
incubated with 1:4,000-diluted peroxidase-labeled streptavidin conjugate in 2
SSPE–0.5% SDS for 1 h and washed in 2 SSPE–0.5% SDS. For chemilumi-
nescent detection of hybridized DNA, the membrane was incubated for 2 min in
20 ml of ECL detection liquid (Amersham, Buckinghamshire, England) and
exposed to a film (Hyperfilm; Amersham, Buckinghamshire, England) for 10
min. Films were subsequently developed (5). For repeated use, the membranes
were stripped and stored at 4°C until further use.
RESULTS
Selection of VD2-PCR primers and probes. In order to de-
tect areas with a high degree of conservation in the VD2
region, multiple sequence alignments from the VD2 region of
12 different strains available in GenBank (Table 1) were per-
formed by using the CLUSTAL W (1.81) program.
On the basis of these alignments, one region with a high
degree of conservation between the different serovars was
identified. This region showed sufficient homology between
the different serovars to allow for the design of two sets of
primers (general and nested primers) to amplify segments of
220 and 166 bp, respectively. The following primers were used
for the VD2 PCR of C. trachomatis: MCTV2S (5-GTATT
YTGTACAYTRGGAGCM-3 biotin) and MCTV2AS (5-
CCYCARTCCCASAYAGCTGC-3) for the primary PCR
and MCTV2N (5-AGGAAAYTCNGCWTCYTTCAA-3 bio)
and MCTV2AN (5-CTGCNCGAGCNCCNACYCT-3) for
the nested PCR. The reaction conditions were optimized by
changing the annealing temperature in the interval from 40 to
60°C and by altering the cycle number. The highest amplifica-
tion sensitivity and efficiency was obtained with an annealing
temperature of 55°C for 50 cycles.
In addition, the region between these primers was suffi-
ciently heterogeneous to allow for the identification of the
different urogenital C. trachomatis serovars by hybridization of
type-specific oligonucleotide probes.
Plasmid PCR and VD2 PCR. In order to compare and de-
termine the sensitivity of the VD2 PCR with the plasmid PCR,
a dilution assay with the different serovars was performed. This
assay showed that the plasmid PCR was able to detect until
0.01 inclusion-forming units (IFU) by using a nonradioactive
enzyme immunoassay (EIA) from all of the different serovars,
whereas the primary PCR was able to detect 0.1 IFU at the
gel level. With the nested VD2 PCR the level of C. trachomatis
detection increased to 0.01 IFU, which was similar to the
results obtained with the plasmid PCR.
Development of the RLB. All oligoprobe sequences selected
for RLB showed a complete matching with the nucleotide
sequence of the corresponding urogenital C. trachomatis sero-
var. Each oligoprobe sequence had at least two mismatches
with a different urogenital C. trachomatis serovar and one
mismatch between variants (i.e., between D and D, J and Jv,
and G and Ga) (Table 2).
To determine the optimal concentration of the oligoprobes
to be used in the RLB, different oligoprobe concentrations
ranging from 100 to 400 pmol/l were applied to the mem-
branes. Subsequently, the membranes were hybridized with
TABLE 1. C. trachomatis serovars analyzed in the present study
Serovar Source GenBankaccession no.
Ba/Apache-2 Conjunctiva AF063194
B/IU-1226 Urine AF063208
D/IC-Ca18 STDa X62920
E/UW5 Cervix X52557
F/IU-1552 Urine AF063212
G/UW57 Cervix AF063199
H/UW4 Cervix X16007
I/UW12 Urethra AF063200
J/IU-1553 Urine AF063206
Jv Urine AF202458
K/IU-1619 Urine AF063207
a STD, sexually transmitted disease.
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VD2 PCR products from the different serovars studied. The
optimal concentrations of oligoprobes to be used in the RLB
were 100 pmol/l for the D, E, K, and G oligoprobes, 200
pmol/l for the I, J, and F oligoprobes, and 400 pmol/l for the
B and H oligoprobes. In addition, the concentration of the
three probes used as positive controls for the B, C, and inter-
mediate groups was 100 pmol/l.
Although this method was developed to identify urogenital
C. trachomatis serovars, additional sequence alignments to se-
lect probes specific for the remaining C. trachomatis serovars
(A to C and L1 to L3) were performed and showed no cross-
reaction in silico with urogenital serovars. These probes can be
tested further in future RLB experiments (data not shown).
Sensitivity and specificity of C. trachomatis typing assay.
Plasmid PCR showed similar detection level as the nested
VD2-PCR with the different urogenital serovars studied. We
made dilution series of the serovar D to compare the level of
sensitivity between the RLB and the plasmid PCR-nonradio-
active EIA assay. Both RLB and EIA reached the same de-
tection level (0.01 IFU). Figure 1 shows dilution series of
serovar D and the level of detection with RLB.
Although in silico investigations did not reveal any cross-
reaction between C. trachomatis probes and nucleotide se-
quences of microorganisms, we also tested the specificity with
a panel of urogenital microorganisms (hemolytic group B
streptococci, Lactobacillus spp., Gardnerella vaginalis, Entero-
bacter cloacae, Klebsiella oxytoca, Escherichia coli, Staphylococ-
cus aureus, Staphylococcus epidermidis, Candida albicans, Can-
dida tropicalis, herpes simplex virus types 1 and 2, Mycoplasma
genitalium, Mycoplasma hominus, Ureaplasma urealyticum,
Neisseria gonorrhoeae, Chlamydia pneumoniae, and Chlamydia
trachomatis). Although some bacteria yielded fragments with
RLB primers in nested PCR, these fragments did not have the
right size and, indeed, after RLB hybridization with specific
C. trachomatis oligoprobes no signals were detected, even after
long exposure.
The specificity of RLB was evaluated further by using VD2
PCR products of the 12 different urogenital serovars studied.
Serovars (D, E, Ba, I, J, K, H, G, and F) showed specific
hybridization, and no cross-reaction was observed between
them even after longer ECL exposure times (see Fig. 1). How-
ever, in our assay it was not possible to differentiate between
variants that had only one mismatch (i.e., D and D, J and Jv,
and G and Ga). In addition, the oligoprobes designed to dif-
ferentiate the three principal groups of C. trachomatis serovars
(group B, group C, and the intermediate group) were specific
and could be used as internal control in the specific serovar
identification (Fig. 1).
Typing of C. trachomatis-positive cervical scrapes. Eighty-six
cervical scrapes initially positive for C. trachomatis plasmid
PCR were subjected to the primary VD2 PCR developed to
identify C. trachomatis infections. The amplified product ob-
tained was used in an RLB for the identification of nine dif-
ferent serovars of C. trachomatis.
Forty-six percent of the samples were typed with this pri-
mary VD2-PCR. To increase the level of detection, the sam-
ples that were negative in the primary PCR were reamplified
by using a nested VD2 PCR, and another 48.22% of the sam-
ples could be identified. In all, 81 of 86 C. trachomatis-positive
samples could be typed (94.2%) by the nested VD2 PCR. A
representative RLB result is shown in Fig. 2. Of the samples
identified by the nested VD2 PCR, 91.3% had single C. tra-
chomatis infections and 8.7% had multiple infections.
The most common serovars identified were serovar D
(22.2% of the positive samples), serovar F (18.5%), serovar G
(13.6%), and serovar E (12.3%) (Table 3). Of the multiple in-
fections, the most common serovars detected were serovars D
and E (4.95%).
TABLE 2. C. trachomatis type-specific oligoprobes
used in RLB typing
Serovara Sequence
D ..................................................GATAATGAAAATCAAAAAACG
D................................................GATAGTGAAAATCAAAAAAC
E ..................................................CAAAGCACGGTCAAAACGAATT
B...................................................AATGGTGCGTTTGTACCAA
Ba.................................................AAATAGTACGTTTGTACCAAT
I....................................................CACAATCTTCTAACTTTAATAC
J ...................................................TCTTTTTCCTAACACTGCTTT
Jv..................................................CTTTTTCCTAACACTGCATT
K ..................................................AACACTGCTTTGGATCGAG
H..................................................ATCTTCTGATTTTAATACAGC
G..................................................GCCACGCAGCCTGCTGCAACA
Ga ................................................AACGTGCAGATAAATCAGTCT
F...................................................ACGAAACCTGCTGCAGATA
Group B......................................AGCTTNGATCAATCTGTTGTT
Group C......................................AACTTAGTTGGATTATTCGGA
Intermediate group....................CTGTGGTGGAACTGTATACA
a Group B (the oligoprobe detected Ba, D, and E serovars), group C (the
oligoprobe detected I, J, K, and H serovars), and the intermediate group (the
oligoprobe detected F and G serovars) are included.
FIG. 1. Standarization of RLB. C. trachomatis type-specific detec-
tion. C. trachomatis serovars amplification by nested VD2 PCR and
detection by RLB. The results for a dilution series of serovar D (101 to
104) and specific detection of serovars E, I, B, J, K, H, G, and F are
shown. Probes are indicated on the y axis, and serovars are indicated
on the x axis.
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DISCUSSION
We developed a novel, sensitive, and simple VD2 PCR-RLB
assay for the typing of urogenital C. trachomatis infections.
This assay is an excellent alternative method for the identifi-
cation of individual and multiple C. trachomatis infections and
has several advantages over other C. trachomatis methods to
identify the most common serovars in terms of speed, usability,
sensitivity, and specificity.
The sensitivity of the nested VD2 PCR is similar to that of
the commonly used C. trachomatis plasmid PCR, which has a
detection limit of 0.01 IFU (9). The nested VD2 PCR results
in a rather small product (166 bp), which is adequate to amplify
samples without high DNA quality from archival smears and
paraffin-embedded biopsies. In addition, the combination of
VD2 PCR and RLB gives an ideal accordance between effi-
cient small-fragment amplification and specific C. trachomatis
typing.
The nested VD2 PCR-RLB showed the same detection level
(0.01 IFU) as the C. trachomatis plasmid PCR when dilution
series of serovar D were used. However, when the cervical
scrapes were analyzed, 5.8% still could not be typed with the
new VD2 PCR-RLB. The false-negative results might be due
to either DNA degradation, low C. trachomatis load, or the
presence of inhibitors in the samples that could not be typed.
Therefore, VD2 PCR-RLB typing can be most reliably used in
samples that are already identified as C. trachomatis positive,
as is the case in the present study with plasmid PCR, which has
been shown to be diagnostically valid.
Initially, we tried to type the samples of the Colombian
cohort by using the omp1 RFLP assay, but we could only type
40% of the samples. The size of the fragment generated in this
PCR is rather large (1.1 kb), which makes this omp1 RFLP
assay sensitive for DNA degradation, thus explaining the low
level of detection with this technique. Therefore, due to the
small size of amplified product, the VD2 PCR-RLB assay is
suitable for the analysis of less-preserved material such as
archival smears and paraffin-embedded tissues, as previously
also shown for the typing of human papillomaviruses with
PCR-RLB (15).
At present the VD2 PCR-RLB technique can identify nine
different urogenital serovars (D, E, Ba, I, J, K, H, F, and
G) and three group-specific probes used as internal control
groups: group B (Ba, D, and E), group C (H to K), and the
intermediate group (F and G). This method cannot differen-
tiate between closely related variants (i.e., D and D, J and Jv,
and G and Ga). The probes selected for the specific identifi-
cation of these variants had only a single mismatch that re-
sulted in cross-reaction with related serovars. Even if we used
more stringent hybridization temperatures, the cross-reaction
remained. Although RLB is a highly specific method, poten-
tially able to differentiate between samples with a single mis-
match, we were only able to differentiate between closely re-
lated serovars when they differed in two or more nucleotides in
sequence. Alternatively, additional probes could be designed
in other regions of the omp1 gene to subsequently subtype and
identify these variants.
Although the focus of the present study was the identifica-
tion of urogenital C. trachomatis serovars, this RLB typing
method can be easily extended to the identification of other
serovars of C. trachomatis.
In the cervical material derived from a population-based
study in Colombia, serovars D, F, G, and E were the most
frequently observed serovars (74.1%). This is in agreement
with other studies performed in different parts of the world (8,
15, 17, 18). With the RLB developed we found that 91.3% of
the women showed single C. trachomatis infections and 8.7%
showed multiple infections. The percentage of multiple infec-
tions identified in our study is in line with those reported in
other studies, where 2 to 15% of the infections contain two or
more serovars (2, 3, 8). The use of this RLB assay facilitates
the detection of multiple infections that are difficult to identify
by the most commonly used methods, such as RFLP and se-
quencing. In addition, the identification of multiple infections
TABLE 3. C. trachomatis serovar distribution in positive samples
from the general population from Colombia as
determined by using RLB
Infection type and serovar(s) n % Positive
Single infections (total) 74 91.33
Ba 0
D (D and D) 18 22.22
E 10 12.35
F 15 18.51
G (G and Ga) 11 13.58
H 3 3.70
I 7 8.64
J (J and Jv) 6 7.40
K 4 4.93
Multiple infections (total) 7 8.67
D and E 3 3.71
D and I 1 1.24
K and H 1 1.24
D, E, and F 1 1.24
G, J, and K 1 1.24
Total 81 100
FIG. 2. Representative example of RLB typing of C. trachomatis
nested VD2-PCR products derived from cervical scrapes. Numbers
indicate the different amplified products of cervical scrapes positive for
C. trachomatis serovars. Samples with multiple infections are shown
(lanes 1, 6, 9, 10, 16, and 20). D, control positive; bl, blank.
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might be important for advancing our knowledge of the natural
history of C. trachomatis infections and for determining wheth-
er there are differential effects for C. trachomatis serovars on
infectivity, immune response, and treatment response.
Finally, the RLB method developed is useful for use in large
epidemiological studies due its advantage to analyze large
number of clinical samples (44 per blot), the comfort to per-
form the assay without requirement of specialized instruments
and the short time required for testing compared to conven-
tional methods (e.g., sequencing and RFLP). For example, the
use of two miniblotters allow typing of up to 84 samples in less
than 1 day, whereas analysis of the conventional RFLP maxi-
mum of 22 samples is more labor-intensive, and it takes at least
1 week to identify a similar number of samples. In addition,
because the RLB method uses a nonprecipitating ECL sub-
strate, it has the advantage that nylon filters can be stripped
and reused at least 10 times (16). Based on the fact that the
VD2 primers are located within the omp1 gene, our RLB
system has a further advantage in that it can also be used for
typing of the PCR-amplified omp1 gene used for RFLP (4, 8,
12, 13).
In conclusion, the nested VD2 PCR-RLB developed is a
simple, fast, and specific method for the identification of indi-
vidual urogenital C. trachomatis serovars and is an appropriate
assay for use in large epidemiological studies to study the
prevalence and persistence of specific C. trachomatis serovars.
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